1h Free Analyst Time
The home blood testing devices market is forecasted to grow by USD 2.95 billion during 2023-2028, accelerating at a CAGR of 4.66% during the forecast period. The report on the home blood testing devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing contagious disease outbreaks, growing demand for convenient blood testing solutions, and rising prevalence of chronic diseases.
The home blood testing devices market is segmented as below:
By Distribution Channel
- Hospital pharmacies
- Online
- Drug stores
By Product Type
- Glucose monitors
- Cholestrol kits
- Coagulation test kits
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the home blood testing devices market covers the following areas:
- Home blood testing devices market sizing
- Home blood testing devices market forecast
- Home blood testing devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Distribution Channel
9 Market Segmentation by Product Type
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global home blood testing devices market: A and D HOLON Holdings Co. Ltd., Abbott Laboratories, ARKRAY Inc., Becton Dickinson and Co., Beurer India Pvt. Ltd., Bio Rad Laboratories Inc., BioMerieux SA, Bionime Corp., Danaher Corp., F. Hoffmann La Roche Ltd., i-SENS, Inc., LifeScan IP Holdings LLC, Medaval Ltd, Microgene Diagnostic Systems Pvt. Ltd., Minaris Medical America, Inc., Nova Biomedical Corp., PixCell Medical Technologies Ltd., Thermo Fisher Scientific Inc., Trajan Scientific Australia Pty Ltd., and Truvian Sciences Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements in home blood testing devices."
According to the report, one of the major drivers for this market is the increasing contagious disease outbreaks.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A and D HOLON Holdings Co. Ltd.
- Abbott Laboratories
- ARKRAY Inc.
- Becton Dickinson and Co.
- Beurer India Pvt. Ltd.
- Bio Rad Laboratories Inc.
- BioMerieux SA
- Bionime Corp.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- i-SENS Inc.
- LifeScan IP Holdings LLC
- Medaval Ltd
- Microgene Diagnostic Systems Pvt. Ltd.
- Minaris Medical America Inc.
- Nova Biomedical Corp.
- PixCell Medical Technologies Ltd.
- Thermo Fisher Scientific Inc.
- Trajan Scientific Australia Pty Ltd.
- Truvian Sciences Inc.
